{"id":3845,"date":"2014-02-10T15:14:51","date_gmt":"2014-02-10T15:14:51","guid":{"rendered":"\/?p=3845"},"modified":"2014-02-10T15:15:07","modified_gmt":"2014-02-10T15:15:07","slug":"cannabis-science-inc-otcmktscbis-remains-red","status":"publish","type":"post","link":"\/articles\/cannabis-science-inc-otcmktscbis-remains-red\/","title":{"rendered":"Cannabis Science, Inc. (OTCMKTS:CBIS) Remains Red"},"content":{"rendered":"

\"69CBIS_chart.png\"The marijuana sector of the OTC markets remains a largely volatile and speculative playground for traders with a high tolerance for risk. The most recent movement of Cannabis Science, Inc. (OTCMKTS:CBIS<\/a>) is more proof of that. After a hurried green run, CBIS<\/a> lost 25% of its share price in two consecutive sessions. <\/p>\n

The company keeps a steady stream of press releases coming, even if they may contain very little information that is of any consequence to shareholders. Last week CBIS<\/a> chimed in to ‘applaud’ the farm bill concerning industrial hemp. This was followed by a news release about CBIS<\/a> cooperating with a non-profit organization to improve awareness and educate both the public and health professionals on the benefits of medical cannabis.<\/p>\n

It seems it’s becoming increasingly trendy to put up PR announcements on this sort of topic as Medical Marijuana, Inc. (OTCMKTS:MJNA<\/a>) also posted a similar one, except it was focused on the benefits of cannabidiol in particular. Unlike MJNA<\/a>, however, CBIS<\/a> did not follow this by more PR related to new contracts and revenue projections in the millions.<\/p>\n

The company is still sitting on its Q3 results that were far from exciting:<\/p>\n

 <\/p>\n